Three cases are presented which emphasize the importance ofhyponatraemia as a cause of grand mal seizures. The combination of hydrochlorothiazide.and amiloride appears to increase the risk of hyponatraemia. We discuss the aetiology and treatmeJrt of hyponatraemia and review the necessity for such combination therapy. We recommend caution in prescribing diuretics and preparations such as Moduretic should be used only in those few patients shown to need potassium supplementation.
Introduction
The aetiology and treatment of diuretic-induced hyponatraemia is controversial. The association between hyponatraemia and the combinedpreparation, Moduretic, has been well described but the literature has emphasized that this is mainly a problem with elderly patients. In this discussion paper we present three cases to illustrate that younger patients can be affected and that they may present with a variety of clinical symptoms including grand-mal seizures. A review of the literature suggests that there are a number of aetiological factors but the evidence from our cases and others suggests that the predominant factor with Moduretic is an excessive sodium loss. Treatment has been highly controversial with recommendations ranging from rapid correction with hypertonic saline to the opposite, aiming for a gradual rise achieved by fluid restriction. In these patients we suggest that the appropriate treatment is sodium repletion.
In the majority of patients the prescription of Moduretic is probably inappropriate. In those few who genuinely need a thiazide diuretic with potassium conservation lower doses could be prescribed.
Cases
Case 1: female aged 69 years Admitted as an emergency complaining of predominantly left iliac fossa abdominal pain and nausea. She had vomited twice in the previous 24 h. She was receiving treatment for hypertension with Metoprolol and two Moduretic tablets daily.
On examination she was apyrexial with no evidence of cardiac failure or peripheral oedema. A provisional diagnosis ofinflamed diverticulae was made and she was treated with intravenous fluids (mainly 5% dextrose) and antibiotics (cefuroxime and metronidazole). Investigations showed a plasma sodium of 121 mmol/l, potassium of 3.1 mmol/l, urea of 3.6 mmol/l, creatinine of 84 I£mol/l,chloride of 84 mmol/l and bicarbonate of 21 mmol/l. Twelve hours later she had a grand mal seizure controlled by 5 mg of diazepam intravenously. Investigations now showed that the plasma sodium had fallen further to 117 mmol/l. Random urinary sodium was 25 mmol/l and osmolality was 178 mosmol. She was given 0.9% sodium chloride intravenously and Moduretic was discontinued. On examination there were no abnormal CNS findings. Within 48 h her plasma sodium was 143 mmol/l. She had no further symptoms or seizures and subsequently had a normal EEG and cranial CT scan. Her plasma sodium has since remained within the normal range.
Case 2: female aged 64 years
Admitted as an emergency with a three week history of nausea, anorexia, abdominal pain, thirst and polyuria. She was receiving treatment for hypertension with oxprenolol, hydralazine and Moduretic two tablets daily. In 1981 she had had a normal EEG following a grand mal seizure and at that time plasma sodium values of 128 and 127 mmol/l had been recorded. On this admission she was drowsy and clinically dehydrated. Blood pressure was 150/80 mmHg lying and 120/70 mmHg standing. There were no other abnormal physical findings. Investigations showed a plasma sodium of 103 mmol/l, potassium of 2.2 mmol/l, chloride of 65 mmol/l, bicarbonate of 28 mmolll, glucose of 8 mmolll, Urea of5.1 mmol/l and creatinine of 60 1'D10l/l. Plasma osmolality was 218 mosmol and urine osmolality was 377 mosmol with a urinary sodium excretion of 58 mmol/lJ24 h. Her central venous pressure was 4 cm below the sternal angle. She was treated with 0.9% sodium chloride intravenously with added potassium. The plasma sodium increased and after 24 h was 118 mmol/l. Twenty-four hours later when her plasma sodium was 125 mmol/l she had a grand mal seizure. On recovery there were no abnormal physical findings in the CNS and she subsequently had a normal EEG and cranial CT scan. Off Moduretic her plasma sodium and urinary electrolytes have remained in the normal range.
Case 3: female aged 64 years This patient had been diagnosed as having temporal lobe epilepsy and was taking phenytoin and phenobarbitone but had had no seizures for at least five years.
She was admitted with a 5 day history of nausea, vomiting and abdominal pain. On examination she was drowsy, clinically normovolaemic with a bloodpressure of 130180 mmHg and a pulse of 80 per min. She was tender in the right hypochondrium. During the examination she had a grand mal seizure. Investigations showed a serumsodium of 100 mmolll, potassiumof3.7 mmolll, ureaof3.7 mmol/l and a glucose of 4.6 mmolll. Random urinary sodium was 61 mmolll, potassium 37 mmolll and osmolality 428 mosmol. A diagnosis of inappropriate ADH secretion was made with possible cholecystitis.
She was treated with a fluid restriction of 500 ml in 24 hours but her confusion increased. Her serum sodium remained at only 102 mmol/l and her urinary osmolality had fallen to 270 mosmol with a low urinary sodium of 5 mmol/l.
It was then ascertained that two weeks before admission she had been commenced on two Moduretic tablets daily for ankle oedema. This had been present for many years.
Following fluid restriction her central venous pressure had fallen but 500 ml of 0.9% sodium chloride raised the serum sodium to 107 mmol/l in 4 h. Three litres of 0.9% saline were given over the next 24 h ensuring that her central venous pressure never exceeded 5 em of water. This raised her serum sodium to 126 mmol/l, her confusion improved and her abdominal pain disappeared. Two days later when her serum sodium was 134 mmol/l she again became confused, agitated, and voiced paranoid ideas.These aymptoms settled within 48 h and she was discharged well and oft'diuretics 4 days later. Her serumsodium has subsequently remained in the normal range. 
Discussion
The evidence suggests that in all three of these cases the seizures were related to hyponatraemia. The maintenance of a normal serum sodium in all subjects when off Moduretic suggests that this drug was the cause.
Mild hyponatraemia, as defined by a serum sodium of 130 mmolll or less, is not uncommon amongst a hospital population with a reported prevalence of 3-5%1,2, but severe hyponatraemia with a serum sodium of less than 110 mmolll is rare (0.2%)1. The prevalence is higher in the elderly (11.2%)3 and in the majority of these is associated with the use of diuretics. It is associated with a significant mortality which is related to the severity of the hyponatraemiav! and has been reported to be as high as 33% in cases where the sodium is below 110 mmol/l'', Acute hyponatraemia, onset less than 24 h is said to have a worse prognosis with a mortality reputedly as high as 50%6 although others have reported a much lower mortality (8%) even in severe hyponatraemia 7 .
The association between hyponatraemia and thiazide diuretics was first emphasized by Fichman". Subsequent reports have attributed 27-50% of all cases of hyponatraemia to diuretics 3,4,7.9. This condition can have a significant morbidity and mortality'P-". Diuretic induced hyponatraemia is more often symptomatic, (73% of all cases"), usually with vague neurological symptoms especially confusion and alteration in conscious level. In more severe cases, as in our three cases, grand mal seizures can occur-". The acute presentation may vary and all of our cases had abdominal pain, two initially presenting to the general surgeons.
Hyponatraemia due to the combination of hydrochlorothiazide and amiloride as in Moduretic has been reported 12.13 and in fact many of the cases in the literature describing thiazide induced hyponatraemia were, in fact, taking Moduretic 10,l1.14-16. This association is particularly common in elderly women 3.17 where patients on Moduretic had a significantly lower sodium than any other diuretic combinatlon'v, Despite these reports the Committee for the Safety of Medicines had only received 69 reports of hyponatraemia by May 1988 (Committee on Safety of Medicines -personal communication). Of interest is the apparent overwhelming association with women, only two cases in the literature being described in men, one of whom was also taking chlorpropamide'P, Although more prevalent in the elderly our cases illustrate that younger patients are also at risk.
The aetiology of thiazide induced hyponatraemia is complex and probably multifactorial. Cases can be associated with obvious salt and water retention with oedema. They can also present with obvious dehydration but more often, as in cases 1 and 3, they present with a clinical normovolaemia. Even then the predominant defect appears to be the loss of sodium in the urine 9.11 • Recognition of sodium depletion in normovolaemic patients can be very difficult 19. The best discriminator seems to be the urinary sodium concentration and in one study all the patients with a concentration less than 30 mmolll responded to intravenous administration of 0.9% sodium chloride'", Since thiazides will induce renal sodium loss, even in the presence ofhyponatraemia, it is important that this estimation is performed when the patient is off the drug. When the test has been performed in this way the urinary sodium has been low in other cases of thiazide induced hyponatraemia'',
The increased prevalence of hyponatraemia with Moduretic is probably due to the additional effect of amiloride on the renal handling of sodium. Amiloride has a direct effect on the distal tubule increasing sodium 10ss20. The effect ofthiazides is mainly on the proximal tubule so the combination compounds the urinary loss of sodium". Sodium deficiency was the major aetiological factor in all three of our cases and other cases of Moduretic induced hyponatraemia in the literature't-'", Thiazide induced hyponatraemia can have a rapid onset 9,l1.22 and although a net loss of sodium was detected it seems insufficient to account for the degree and rapidity of its development. In all three cases in the literature a reduction in free water clearance was also detected. Ther~l8I'e several possible mechanisms for such a reduction. Hyponatraemia can cause it directly by limiting the delivery of sodium to the distal nephron 23 ,24. Thiazides also have a direct action on the nephron reducing free water clearances", (although this effect may be difficult to distinguish from that of hyponatraemia alone'").
Antidiuretic hormone (ADH) levels have been reported to be elevated" and some'" have pointed out the similarity with the syndrome of inappropriate ADH release. ADH levels in other cases of hyponatraemia have been normal!' and the finding of a low urinary sodium is not compatible with the diagnosis of inappropriate ADH release 28 • The increase in ADH, when detected, can be attributed to the appropriate stimuli of hypovolaemia and nausea'". Our third case illustrates the difficulty in establishing the correct diagnosis. Her initial clinical picture and biochemistry were compatible with inappropriate ADH release but the subsequent low urinary sodium, (when measured off Moduretic), her deterioration with fluid restriction and the improvement with saline virtually exclude this diagnosis. Whatever the mechanism of its release an elevation of ADH could exacerbate hyponatraemia and this could be compounded by the synergistic effect that thiazides have on the ADH mediated increase in renal tubular permeability to water".
In his series Fichman noted a mild reduction in exchangeable sodium with an increase in residual sodium. He postulated that the major factor inducing hyponatraemia was an intracellular shift of salt and water secondary to hypokalaemias. Potassium replacement alone can raise serum sodium levels 30. Our third case did not have hypokalaemia nor did many others reported in the literature 3,9-14.16 and experimentally a rapid fall in serum sodium can be induced without a deficit in body potassium 9.11,22. Thus hypokalaemia may be a contributing factor especially in oedematous cases 30 but is unlikely to be the primary cause of hyponatraemia in the majority of patients.
A further reduction in serum sodium can be attributed to the administration of hypotonic fluids. This may be iatrogenic (as incase 1) or be fluid replacement as a consequence of thirst. The effect of diuretics on the renal handling of salt and water combined with large volumes of hypotonic fluid can rapidly induce severe hyponatraemia'", an effect that may not have occurred with either factor alone.
Thus the development ofhyponatraemia in patients taking thiazides can involve sodium depletion, reduced free water clearance and water overload but the contribution of each may vary. The addition of amiloride increases the importance of sodium depletion.
The cause ofthe transient neurological deterioration, as in case 3, is well described following the treatment of severe hyponatraemia'P but the cause has been the subject of heated debate. Some argue that it is due to delayed and slow correction of serum sodium 5, 33-35. Others have suggested that the neurological complications are largely iatrogenic, consequent on too rapid a rate of correction 32,36,37.
The debate centres on the development of a rare intracerebral lesion, central pontine myelinolysis (CPM) first described by Adams and co-workers in malnourished alcoholics'", The clinical picture varies but consists mainly of a decrease in conscious level associated with a flaccid or spastic quadraplegia and associated pseudobulbar lesions. Histologically discrete areas of demyelination are found in the pons but similar lesions have been described in other areas of the brain 39. The lesions may be detectable antemortem by abnormalities of visually evoked potentials or MRI scanning'", An association with electrolyte disorders especially hyponatraemia has been described 41,42 and this may be secondary to diuretics 32,42. Tomlinson described two cases of CPM and suggested that they might have been associated with the rapid correction of hyponatraemia using hypertonic salinev' and this view has been supported by others 32,37,45. Others, however, have reported that the rapid correction of hyponatraemia with hypertonic saline carries a good prognosis'" and, provided overcorrection is avoided, is the therapy of choice 33,34. Several studies in animals have examined the effects of hyponatraemia on the brain and the effect of treatment. Following the acute reduction in serum sodium there is little change in brain electrolytes maintaining a large osmotic gradient and cerebral oedema can develop". With increasing duration of hyponatraemia compensatory mechanisms occur and the electrolyte" and amino acid 47 concentrations within the brain fall resulting in a reduction of the osmotic gradient", Thus in chronic hyponatraemia brain electrolyte concentrations are similar to plasma with only a small increase in brain water6,47. It is therefore to be expected that the effect of different modes of treatment will depend on the duration of the hyponatraemia. Induction of hyponatraemia in animals carries a high mortality48,49 but does not appear to induce cerebral lesions similar to CPM in rats 48,50, dogs 49, rabbits'" or micef". Administration of hypertonic saline alone did not.induce lesions in normonatraemic animals 48,49. Correction of hyponatraemia however did induce cerebral dehydration'? and demyelination 49-51. Many of the animals were however corrected to normonatraemic levels and rapid correction with saline to achieve a lower sodium level (mean of 130 mmol/l) produced small and clinically insignificant lesions in only two out of 16 animals". Correction to hypernatraemic levels either by fluid restriction or hypertonic saline induced cerebral lesions'", Caution should be exercised in extrapolating the results from animal experiments to the treatment of hyponatraemia in humans. In all the animal Journal of the Royal Society of Medicine Volume 82 August 1989 481 experiments hyponatraemia was induced by water intoxication alone while we have already shown that the clinical picture, especially with diuretic induced hyponatraemia, is more complex involving saline depletion and possibly hypokalaemia and elevated levels of ADH. The literature has concentrated on debating the rate of sodium correction 5,36 and confused other variables such as the duration of hyponatraemia, its aetiology and the level to which the sodium is corrected. Furthermore, many of the cases of CPM reported occurred in conjunction with alcohol abuse making it difficult.to substantiate any claim for an effect of treatmentv. Many of the studies are retrospective and do not compare similar groups, eg a significantly lower serum sodium level in those developing CPM34 or the additional effect of hypoxia34, 35. Another possible factor in inducing cerebral oedema is ADH. Infusion of vasopressin intracerebrally increases capillary permeability to water5 2 • Although untested it is probable that some of the patients with elevated ADH levels in the peripheral blood also have raised levels in the CSF thereby increasing the risk of cerebral oedema on rehydration.
A consensus on treatment does seem to emerge. In the majority of cases with mild hyponatraemia who are asymptomatic the prognosis is good and treatment will depend on the aetiology. In cases secondary to diuretics withdrawal of the drug and mild fluid restriction is usually all that is required. Saline therapy should be reserved for those who are significantly hypovolaemic. In cases who are symptomatic especially with severe hyponatraemia (less than 110 mmol/l) rapid recognition and treatment is required. Ifhypovolaemic, 0.9% is infused but in acute cases especially with predominant water overload, initial therapy with hypertonic saline (3%) is probably justified. In those at risk of circulatory overload the addition of loop diuretics facilitates water excretion and may be advantageous'", As advised by Arieff et al. care should be taken to avoid correcting the sodium by more than 25 mmolll in 48 h and one should aim for a level of approximately 120-125 mmol/P'. Diuretic-induced hyponatraemia is likely to be more chronic and it must be established whether it is due to predominant water overload or sodium depletion. With the latter sodium replacement should be the primary treatment. Whether this is with isotonic (0.9%) or 3% saline will depend upon the degree of volume depletion as measured by the central venous pressure. The aim should be to improve symptoms and increase the plasma sodium to low normal levels (120-125 mmol/l) remembering that the withdrawal ofthiazides may facilitate a water diuresis which can further increase the serum sodium. In more chronic cases with predominant water overload correction should be gradual with fluid restriction and 3% saline only used initially to increase the sodium from' dangerous levels.
The evidence from our three cases and others in the literature 9, 16 suggests that in cases secondary to Moduretic sodium deficiency is likely and, saline repletion rather than fluid restriction is the preferred treatment. Case 3 illustrates that these patients will not respond to fluid restriction alone and suggests that even here it is wise not to raise the sodium into the normal range too soon.
All cases of severe hyponatraemia require careful monitoring of intravascular volume, urine output and respiratory status and ideally should be nursed on an intensive therapy unit. The cases presented and the review of the literature would argue strongly against the view that hyponatraemia is always a benign condition and should be treated with 'masterly inactivity'{.
All three of our cases were taking two Moduretic tablets daily which comprises 100 mg hydrochlorothiazide and 10 mg amiloride. Cases 1 and 2 were prescribed diuretics for hypertension and case 3, inappropriately, for dependent oedema. The addition of amiloride is designed to correct hypokalaemia but may induce other problems. It is therefore pertinent to discuss the importance of hypokalaemia, its prevention and modes of treatment. This topic has also been the subject of intense debate 54 • 55.
The addition of a thiazide diuretic will induce a mean reduction in serum potassium of about 0.6 mmolll usually within the first few weeks of therapy56. It is only a minority of patients who will develop actual hypokalaemia (plasma value less than 3.5 mmolll 56 -58. The prevalence increases in elderly women but is still less than 50%59. Hypokalaemia can be associated with direct myocardial and renal toxicity54 but the levels in the patients were much lower than those induced by diuretics alone. The number of ventricular extrasystoles increases with a reduction in plasma potassium and can improve with replacement'", This is particularly important following myocardial infarction where the frequency of cardiac arrhythmias is much higher in hypokalaemic patients, the majority of whom were taking diuretics. Maintenance of potassium is particularly important in patients on digoxin where hypokalaemias" and the associated metabolic alkalosis 63 may increase the risk of digoxin toxicity.
Diuretics may be prescribed for heart failure but these patients usually have a higher initial serum potassium'", Since digoxin is probably of little value in the majority of patients in sinus rhythm 64 it is probably only a small proportion of these patients who will need long-term potassium supplementation. With the increasing use of ACE inhibitors, which have a potassium sparing effect 65 , the number of patients in chronic heart failure requiring potassium supplements is likely to be small.
In the treatment of hypertension the majority of the effect of thiazides is achieved with small doses, equivalent to 25 or 50 mg of hydrochlorothiazide 66 • 67 • The development of hypokalaemia with thiazides is dose dependent and the reduction associated with such doses is small 56 • 57 • 66 ,67. Thus questioning the need for diuretic therapy and if it is necessary using the lowest effective dose will considerably reduce the prevalence of hypokalaemia. For the small number of patients who need potassium replacement, drugs such as amiloride are probably more effective than potassium supplements in maintaining total body potassium'", If amiloride is to be used it is wise to commence with a smaller dose (5 mg) which is now available in combination with 25 mg of hydrochlorothiazide as Moduret 25.
The frequency and severity of electrolyte disorders should not be underestimated. All patients should have their electrolytes checked shortly after commencing treatment, again after approximately six months and at times of intercurrent illness. Rapid recognition and appropriate therapy combined with more prudent prescribing should reduce the prevalence, morbidity and mortality of hyponatraemia. This association is not confined to the elderly and is important to all who practice acute medicine.
